Low-dose direct oral anticoagulants tied to more bleeding episodes
Jun 19, 2024
The findings compared with standard doses in patients with atrial fibrillation.
Reteplase superior to alteplase within 4.5 hours of ischemic stroke
Jun 20, 2024
Reteplase was more likely to result in excellent functional outcome than alteplase for ischemic stroke within 4.5 hours of symptom onset.
Fewer adults eligible for statins with PREVENT equations
Jun 21, 2024
Compared with the pooled cohort equations, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex and racial subgroups, with the largest difference seen for Black...
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
Antibiotics not helpful for cough due to lower respiratory tract infection
Apr 25, 2024
Despite patient beliefs, no effect was seen on the severity or duration of the cough.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
Risk for dementia reduced in association with antihypertensive use
Sep 13, 2023
An individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension.
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.